Literature DB >> 21506095

American College of Rheumatology Clinical Trial Priorities and Design Conference, July 22-23, 2010.

.   

Abstract

Mesh：

Year:  2011        PMID： 21506095     DOI： 10.1002/art.30402

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  7 in total

Review 1.  Systematic review of tumor necrosis factor inhibitor discontinuation studies in rheumatoid arthritis.

Authors:  Iris Navarro-Millán; Sebastian E Sattui; Jeffrey R Curtis
Journal:  Clin Ther       Date:  2013-10-22       Impact factor: 3.393

2.  Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trial.

Authors:  James R O'Dell; Jeffrey R Curtis; Ted R Mikuls; Stacey S Cofield; S Louis Bridges; Veena K Ranganath; Larry W Moreland
Journal:  Arthritis Rheum       Date:  2013-08

3.  A randomised efficacy and discontinuation study of etanercept versus adalimumab (RED SEA) for rheumatoid arthritis: a pragmatic, unblinded, non-inferiority study of first TNF inhibitor use: outcomes over 2 years.

Authors:  Paresh Jobanputra; Fiona Maggs; Alison Deeming; David Carruthers; Elizabeth Rankin; Alison C Jordan; Abdul Faizal; Carolyn Goddard; Mark Pugh; Simon J Bowman; Sue Brailsford; Peter Nightingale
Journal:  BMJ Open       Date:  2012-11-12       Impact factor: 2.692

4.  Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonists.

Authors:  Axel Finckh; Burkhard Möller; Jean Dudler; Ulrich A Walker; Diego Kyburz; Cem Gabay
Journal:  Ann Rheum Dis       Date:  2012-03-14       Impact factor: 19.103

5.  Pre-treatment whole blood gene expression is associated with 14-week response assessed by dynamic contrast enhanced magnetic resonance imaging in infliximab-treated rheumatoid arthritis patients.

Authors:  Kenzie D MacIsaac; Richard Baumgartner; Jia Kang; Andrey Loboda; Charles Peterfy; Julie DiCarlo; Jonathan Riek; Chan Beals
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

Review 6.  Scoping review of priority setting of research topics for musculoskeletal conditions.

Authors:  Allison M Bourne; Renea V Johnston; Sheila Cyril; Andrew M Briggs; Ornella Clavisi; Gustavo Duque; Ian A Harris; Catherine Hill; Claire Hiller; Steven J Kamper; Jane Latimer; Andrew Lawson; Chung-Wei Christine Lin; Christopher Maher; Diana Perriman; Bethan L Richards; Peter Smitham; William John Taylor; Sam Whittle; Rachelle Buchbinder
Journal:  BMJ Open       Date:  2018-12-16       Impact factor: 2.692

7.  Is radiographic progression in modern rheumatoid arthritis trials still a robust outcome? Experience from tofacitinib clinical trials.

Authors:  Robert B M Landewé; Carol A Connell; John D Bradley; Bethanie Wilkinson; David Gruben; Sander Strengholt; Désirée van der Heijde
Journal:  Arthritis Res Ther       Date:  2016-09-23       Impact factor: 5.156
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.